2,2,4,4,6,6-Hexamethyl-1,3,5-trithiane, 95.0%, 500g

5-chloro-6-nitro-2,3-dihydro-1H-indole, 95.0%, 5g

Phthaloyl Chloride>98.0%(T)100g

2-(2-CHLOROPHENYL)-2-PYRROLIDINYLETHYLAMINE 2HCL, 95.0%, 100mg

(4R,5R)-1,3-Dimesityl-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate, 98%, 100mg

Methyl 5-fluoro-1H-indole-2-carboxylate, 95.0%, 25g

(4-Pyridyl)methylhydrazine dihydrochloride, 95.0%, 1g

3-Hydroxy-5-nitrobenzoic acid, 95.0%, 5g

Long working distance plan phase 4x/0.13 IOS objective, working distance 10.75 mm

trans,trans-4'-Butylbicyclohexyl-4-carboxylic Acid>98.0%(GC)(T)5g

1-Ethyl-3-methylpyrazole-5-carboxylic acid, 85.0%, 500g

5-(chloromethyl)-3-cyclohexylisoxazole, 95.0%, 1g

N-(Chloroacetyl)-4-(trifluoromethoxy)aniline, 97.0%, 1g